GRI Financials: Income Statement, Balance Sheet & Cash Flow

NodeGuardian · 2026-03-01T05:30:20+00:00

The article analyzes GRI Bio's financials for FY2025, revealing a net loss of $12M, low profitability, and poor financial health, as indicated by a Piotroski F-Score of 2/9 and low earnings quality reliant on accounting accruals.

NodeGuardian

2026-03-01 05:30:20

Abstract generation in progress

This article provides a detailed financial overview of GRI Bio (GRI), including its income statement, balance sheet, and cash flow for the fiscal years ended 2025. Key metrics show GRI Bio is not profitable, reporting a net income of -$12.0M and diluted EPS of $-121.80 in FY2025. The company also demonstrates weak financial health with a Piotroski F-Score of 2/9 and low earnings quality, indicating earnings are primarily driven by accounting accruals rather than cash generation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.